Kimberly-Clark (KMB) reported earnings on Fri 23 Apr 21 (b/o)

• Missed consensus for Q1 EPS and revs. Sales declined 8% yr/yr on anorganic basis. Comparisons were impacted by lapping COVID-19 stockpiling trends from the year-ago period, as well as consumer tissue category softness and commodity inflation; co also experienced temporary supply chain disruptions in the southern US. Lowered its outlook for FY21 EPS and sales growth, reflecting significantly higher input cost inflation and lower sales volumes.

  ** charts after earnings **

 

Kimberly-Clark misses by $0.14, misses on revs; slightly lowers FY21 EPS, revs outlook

• Reports Q1 (Mar) earnings of $1.80 per share, excluding non-recurring items, $0.14 worse than the S&P Capital IQ Consensus of $1.94; revenues fell 5.3% year/year to $4.74 bln vs the$4.97 bln S&P Capital IQ Consensus.
• Co issues guidance for FY21, sees EPS of $7.30-7.55, excluding non-recurring items, (from$7.75-8.00) vs. $7.77 S&P Capital IQ Consensus; sees FY21 sales growth of +3-5% (prior +4-6%) which equates to about $19.67-20.06 bln vs. $19.99 bln S&P Capital IQ Consensus.

Earnings this week : Apr 19 - 23, 2021 (wk 16)

Monday (Apr 19)

• Morning:  KO MTB ONB PLD
• Afternoon: ACC CCK ELS FNB HXL IBM PNFP STLD UAL WTFC ZION

Tuesday (Apr 20)

• Morning: ABT AN BMI CMA DOV FITB GATX HOG IRDM JNJ KEY LMT MAN EDU NTRS OMC PM PG SFNC SNV TRV WBS XRX
• Afternoon:  CSX EW FMBI FULT HWC IBKR ISRG NFLX LRN THC UCBI WRB

Wednesday (Apr 21)

• Morning:  ANTM ASML BKR BOKF ERIC FHN FCFS HAL HCSG KNX LAD NDAQ NEE NEP NVR RCI SBNY TEL VZ
• Afternoon:  BXS BDN CACI CP CMG CHDN CNS CLB CCI DFS EFX FR GL GGG KMI LRCX LSTR LVS NTGR NWE PLXS XM REXR RLI RHI SLM SEIC SLG SNBR STL TCBI UFPI UMPQ VMI WHR

Thursday (Apr 22)

• Morning: ALK ALLE AAL AEP ARCH T AUB BANC BKU BIIB BX CADE GTLS CLF DHI DHR DOW EWBC FAF FCX GPC HCA HRI HBAN IQV HZO MKTX NUE ODFL ORI PNR POOL PDS DGX RS SASR SAP SITC SNA SON LUV TAL TSCO TPH TRN UNP VLO WSO WNS
• Afternoon:  ABCB ASB OZK BJRI SAM CAMP CSL CE BOOM EIG FFBC FE GBCI HTH INTC KN MAT NBHC PBCT STX SKX SNAP SIVB VRSN VICR WWE

Friday (Apr 23)  

• Morning:  AXP ALV AZZ FHB GNTX HON KMB RF SLB SXT SBSI

Kimberly-Clark (KMB) reported earnings on Thur 22 Oct 2020 (b/o)

 ** charts after earnings **

 

Kimberly-Clark CEO Michael Hsu

Kimberly-Clark products

Kimberly-Clark misses by $0.01, beats on revs; raises FY20 EPS and revenue guidance

Reports Q3 (Sep) earnings of $1.72 per share, excluding non-recurring items, $0.01 worse than the S&P Capital IQ Consensus of $1.73; revenues rose 0.9% year/year to $4.68 bln vs the $4.59 bln S&P Capital IQ Consensus.

Co issues guidance for FY20, sees EPS of $7.50-7.65, excluding non-recurring items, vs. $7.70 S&P Capital IQ Consensus and vs prior guidance of $7.40-7.60; raises FY20 revenue growth rate to +2-3% from +1-2%; we compute the new guidance as $18.82-19.00 bln vs. $18.84 bln S&P Capital IQ Consensus.

=Kimberly-Clark (KMB) reported earnings on Wed 23 Jan 2019 (b/o)

Kimberly-Clark misses by $0.06, beats on revs; guides FY19 below consensus; announces K-C Strategy 2022 medium-term financial objectives 

• Reports Q4 (Dec) earnings of $1.60 per share, excluding non-recurring items, $0.06 worse than the S&P Capital IQ Consensus of $1.66; revenues fell 0.7% year/year to $4.57 bln vs the $4.47 bln S&P Capital IQ Consensus. Changes in foreign currency exchange rates reduced sales by 4%. Organic sales increased 3%, as net selling prices improved 3%. Organic sales declined 1% in the year-ago period. In North America, organic sales increased 6% in K-C Professional, and 3% in consumer products compared to a 3% decline in the base period. Outside North America, organic sales rose 4% in developing and emerging markets and were even year-on-year in developed markets.
• Co issues downside guidance for FY19, sees EPS of $6.50-6.70, excluding non-recurring items, vs. $6.78 S&P Capital IQ Consensus; sees FY19 revs of down 1-2% to ~$18.12-18.30 bln vs. $18.3 bln S&P Capital IQ Consensus. Foreign currency exchange rates unfavorable by 3 to 4%. Exited businesses in conjunction with the 2018 Global Restructuring Program expected to reduce sales slightly, mostly in K-C Professional. Organic sales increase of 2%, driven by higher net selling prices of at least 3%. Adjusted operating profit growth of 1 to 4%.
• K-C Strategy 2022:
  • The company will target to grow sales in-line with, or slightly ahead of, category growth rates. Kimberly-Clark's three growth pillars are to elevate core businesses, accelerate growth in D&E markets and drive digital marketing and e-commerce. The company expects to achieve these pillars by launching differentiated product innovations, driving category development and leveraging commercial capabilities in sales and marketing.
  • The company will generate savings in order to fund growth initiatives and improve margins. Focus areas will include driving ongoing supply chain productivity improvements through the FORCE program, executing the 2018 Global Restructuring Program, rigorously controlling discretionary spending to sustain the company's top-tier overhead cost structure and driving further improvement in working capital.
  • The company will allocate capital in value-creating ways, enabled by strong cash generation. Kimberly-Clark expects to spend capital at an annual rate of 4 to 5% of net sales after completing the 2018 Global Restructuring Program. In addition, the company plans to return significant amounts of cash to shareholders through dividends and share repurchases.
• The company's medium-term financial objectives associated with K-C Strategy 2022 assume that category growth remains relatively modest and similar to recent conditions. The objectives are as follows:
  • Sales and organic sales growth - 1 to 3% annually.
  • Adjusted earnings per share growth - mid-single digits annually.
  • Adjusted Return On Invested Capital - at least maintain at current level.
  • Dividend growth - generally in line with adjusted earnings per share growth.

Earnings this week : Jan 21 - 25, 19 (wk 4)

Earnings confirmed to report this week:

Monday (Jan 21)    

• Market closed for Martin Luther King Jr. Day

Tuesday (Jan 22)

• Morning: ATI FITB GATX HAL HMST JNJ LOGI EDU PETS PLD SWK TRV
• Afternoon: AMTD CNMD COF FMBI HOPE IBKR IBM LRN LTXB NAVI RNST SFNC TBK UCBI WTFC ZION

Wednesday (Jan 23)

• Morning:  ABT APH ASML BKU BPOP CBU CMCSA HZO KMB NTRS PG PGR RES ROL SYF TDY TEL UTX WAT
• Afternoon:  ADTN AZPN BGG BXS CATY CCI CMRE CNS CP CTXS CVBF F FFBC FFIV HXL LRCX  LVS NXGN PTC RJF SLG SLM STL TCBI TER TRMK TXN UMPQ URI VAR XLNX

Thursday (Jan 24)

• Morning:  AAL AEP AIT AVX BANC BMY COLB DLX EWBC FCX GWW HBAN ISCA JBLU LUV MKC MMYT ORI RCI STM TAL TXT UNP VIVO WBS
• Afternoon: ALK ASB AVT CUBI DFS  ETFC FHB FII HTH INTC ISRG NBHC NSC OSIS RMD SBCF SBUX SIVB WAL WDC

Friday (Jan 25)

• Morning: ABBV ABCB APD CL DHI ERIC HRC IBKC LEA MOG.A NEE

Kimberly-Clark (KMB) reported earnings on Fri 22 Apr 2016 (b/o)

** charts after earnings **

 

Kimberly-Clark beats by $0.02, misses on revs; reaffirms FY16 guidance :

• Reports Q1 (Mar) earnings of $1.53 per share, $0.02 better than the Capital IQ Consensus of $1.51; revenues fell 4.6% year/year to $4.48 bln vs the $4.54 bln Capital IQ Consensus.
  • Performance benefited from organic sales growth, cost savings, input cost deflation and a lower adjusted effective tax rate. Comparisons were negatively impacted by unfavorable foreign currency exchange rate effects and increased marketing, research and general spending on a local currency basis. Adjusted earnings per share in both years exclude certain items described later in this news release.
• Co reaffirms guidance for FY16, sees EPS of $5.95-6.15 vs. $6.15 Capital IQ Consensus Estimate. Continues to expect our organic sales to grow 3 to 5 percent. Compared to the first quarter, KMB expects more benefits from targeted growth initiatives, product innovations and improved net realized revenue.

Kimberly-Clark (KMB) reported 4Q earnings on Mon 25 Jan 2016 (b/o)

** charts before earnings **

 

** charts after earnings **

 

Kimberly-Clark misses by $0.01, reports revs in-line; guides FY16 below estimates :

• Reports Q4 (Dec) earnings of $1.42 per share, excluding non-recurring items, $0.01 worse than the Capital IQ Consensus of $1.43; revenues fell 6.0% year/year to $4.54 bln vs the $4.57 bln Capital IQ Consensus. 
  • Changes in FX reduced sales 11% as a result of the weakening of most currencies relative to the U.S. dollar. Organic sales rose 5%, as volumes increased 4% and net selling prices improved 1%.
• Earnings performance benefited from organic sales growth, cost savings, input cost deflation and a lower share count. Comparisons were negatively impacted by unfavorable foreign currency exchange rate effects, increased marketing, research and general spending on a local currency basis and higher other expense.
• Co issues downside guidance for FY16, sees EPS +3-7% to $5.95-6.15, excluding non-recurring items, vs. $6.14 Capital IQ Consensus; sees FY16 revs -3% to flat to ~$18.0-18.6 bln vs. $18.7 bln Capital IQ Consensus.
  • Organic sales growth of 3 to 5%, with volumes up 2 to 3% and changes in net selling prices and product mix, combined, up an additional 1 to 2%. Negative foreign currency exchange rate impact of 5 to 6%. Adjusted operating profit growth of 2 to 5%. 
  • Dividend expected to increase mid-single digits, subject to approval by the Board of Directors.

KMB — is it a sell?

• Jan 20:  Is KMB a sell?

• Jan 22: NO